Home

Recent Articles from GlobeNewswire

Junshi Biosciences Announces FDA’s Approval of IND Application for Phase 2/3 Clinical Study of JS207 for the Neoadjuvant Treatment of NSCLC Patients
SHANGHAI, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the investigational new drug (“IND”) application for an open-label, two-arm, randomized, active-controlled, phase 2/3 clinical study comparing the company’s product, recombinant humanized anti-PD-1/VEGF bispecific antibody (code: JS207), to nivolumab for the neoadjuvant treatment of patients with stage Ⅱ/Ⅲ, resectable, actionable genomic aberration (AGA)-negative, non-small cell lung cancer (“NSCLC”) has been approved by the U.S. Food and Drug Administration (the “FDA”).
By Junshi Biosciences · Via GlobeNewswire · October 16, 2025
The Hemp Doctor Debuts 6.5G THC Disposable Vape: Bolder & Stronger Than Ever
By The Hemp Doctor · Via GlobeNewswire · October 16, 2025
RCI Hospitality Holdings, Inc. INVESTOR ALERT: Kirby McInerney LLP Notifies RCI Hospitality Holdings, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds RCI Hospitality Holdings, Inc. (“RCI” or the “Company”) (NASDAQ:RICK) investors of the November 20, 2025 deadline to seek the role of lead plaintiff in a pending federal securities class action.
By Kirby McInerney LLP · Via GlobeNewswire · October 16, 2025
South Bow Announces Timing of Third-quarter 2025 Results and Conference Call and Webcast
CALGARY, Alberta, Oct. 16, 2025 (GLOBE NEWSWIRE) -- South Bow Corp. (TSX & NYSE: SOBO) (South Bow or the Company) will release its third-quarter 2025 financial and operational results after the close of markets on Nov. 13, 2025.
By South Bow Corporation · Via GlobeNewswire · October 16, 2025
SMTC Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Semtech Corporation – SMTC
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of Semtech Corporation (NASDAQ: SMTC).
By The Rosen Law Firm PA · Via GlobeNewswire · October 16, 2025
PUBM DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages PubMatic, Inc. Investors to Secure Counsel Before Important October 20 Deadline in Securities Class Action – PUBM
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · October 16, 2025
Phlow Corp. Selected by the U.S. Food and Drug Administration Commissioner’s First-Ever National Priority Voucher Pilot Program to Advance Manufacturing of a Critical Essential Medicine in America
RICHMOND, Va, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), today announced that the active pharmaceutical ingredient for ketamine will be included in the first-ever U.S. Food and Drug Administration (FDA) Commissioner’s National Priority Voucher (CNPV) Pilot Program. This designation recognizes Phlow’s leadership in advancing domestic manufacturing of essential and life-changing medicines in the United States.
By Phlow Corp. · Via GlobeNewswire · October 16, 2025
AVITA Medical Announces CEO Transition
VALENCIA, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical”, or the “Company”), a leading therapeutic acute wound care company, today announced that the Board of Directors has named Chairman of the Board Cary Vance as Interim Chief Executive Officer, effective immediately. In conjunction with this appointment, Jim Corbett is leaving his positions as CEO and member of the Board. Mr. Vance will continue to serve as Chairman of the Board, while Board member Jan Stern Reed has been appointed Lead Independent Director.
By AVITA Medical · Via GlobeNewswire · October 16, 2025
Fortinet, Inc. INVESTOR ALERT: Kirby McInerney LLP Notifies Fortinet, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Fortinet, Inc. (“Fortinet” or the “Company”) (NASDAQ:FTNT) investors of the November 21, 2025 deadline to seek the role of lead plaintiff in a pending federal securities class action.
By Kirby McInerney LLP · Via GlobeNewswire · October 16, 2025
FREEPORT INVESTIGATION: Bragar Eagel & Squire, P.C. Urges Freeport-McMoran Inc. Stockholders to Contact the Firm Regarding Ongoing Investigation
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Freeport (FCX) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 16, 2025
FIREFLY AEROSPACE INVESTIGATION: Bragar Eagel & Squire, P.C. Continues Investigation into Firefly and Reminds Firefly Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Firefly (FLY) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 16, 2025
MGPI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation into MGP Ingredients, Inc. on Behalf of Long-Term Stockholders
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In MGP Ingredients (MGPI) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 16, 2025
CARMAX INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Urges CarMax Investors to Contact the Firm Regarding Ongoing Investigation
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In CarMax (KMX) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 16, 2025
JAMES HARDIE INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds Investors of James Hardie Industries to Contact the Firm Regarding the Ongoing Investigation on Behalf of James Hardie Stockholders
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In James Hardie (JHX) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 16, 2025
AVITA MEDICAL INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Avita (RCEL) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 16, 2025
Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)
WATERTOWN, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it received a Commissioner’s National Priority Voucher (CNPV) from the U.S. Food and Drug Administration (FDA) for bitopertin in erythropoietic protoporphyria (EPP), including X-linked protoporphyria (XLP). Disc submitted a New Drug Application (NDA) to the FDA for bitopertin for patients aged 12 years and older with EPP following the FDA’s accelerated approval pathway in September 2025. Bitopertin has received Orphan Drug Designation and Rare Pediatric Disease Designation from the FDA.
By Disc Medicine Inc · Via GlobeNewswire · October 16, 2025
CVS INVESTIGATION: Bragar Eagel & Squire, P.C. Continues Investigation into CVS Health Corporation on Behalf of Long-Term Stockholders and Urges Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In CVS (CVS) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 16, 2025
EDISON INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation into Edison International on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Edison (EIX)To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 16, 2025
ROCKET DOCTOR AI INC. ANNOUNCES ENGAGEMENT OF FN MEDIA GROUP
Vancouver, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Rocker Doctor AI Inc. (the “Company” or “Rocket Doctor AI”) (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) announces that it has engaged FN Media Group, LLC (“FN Media”) to commence news/media marketing campaigns for a three (3) day term commencing the week of October 20, 2025, in  consideration of USD$14,085.
By Rocket Doctor AI Inc. · Via GlobeNewswire · October 16, 2025
ALLOVIR INVESTIGATION: Bragar Eagel & Squire, P.C. Continues Investigation into AlloVir, Inc. on Behalf of Long-Term Stockholders
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In AlloVir (ALVR) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 16, 2025
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH), SWK Holdings Corporation (Nasdaq – SWKH)
BALA CYNWYD, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · October 16, 2025
TC Energy to host third quarter 2025 conference call on Nov. 6
CALGARY, Alberta, Oct. 16, 2025 (GLOBE NEWSWIRE) -- News Release – TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) will hold a teleconference and webcast on Thursday, Nov. 6, 2025, to discuss its third quarter financial results. The event will also include an update to the Company’s financial outlook along with other developments.
By TC Energy Corporation · Via GlobeNewswire · October 16, 2025
North American Construction Group Ltd. Third Quarter Results Conference Call and Webcast Notification
ACHESON, Alberta, Oct. 16, 2025 (GLOBE NEWSWIRE) -- North American Construction Group Ltd. (“NACG” or “the Company”) (TSX:NOA.TO/NYSE:NOA) announced today that it will release its financial results for the third quarter ended September 30, 2025 on Wednesday, November 12, 2025 after markets close. Following the release of its financial results, NACG will hold a conference call and webcast on Thursday, November 13, 2025, at 7:00 a.m. Mountain Time (9:00 a.m. Eastern Time).
California Resources Corporation Breaks Ground on California’s First Carbon Capture and Storage Project
Groundbreaking for Carbon TerraVault I Marks Major Milestone in California’s Clean Energy Future
By California Resources Corporation · Via GlobeNewswire · October 16, 2025
SGBX Subsidiary Olenox to Implement AI Algorithm to Streamline Wellsite Production and Operator Input
Phase 1 of intelligent wellsite monitoring system completed; Phase 2 to launch real-time shareholder dashboard
By Safe and Green Holdings Corp. · Via GlobeNewswire · October 16, 2025
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
BALA CYNWYD, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · October 16, 2025
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD), PB Bankshares, Inc. (Nasdaq - PBBK), Air Lease Corporation (NYSE – AL)
BALA CYNWYD, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · October 16, 2025
LAMB WESTON INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds Long-Term Lamb Weston Holdings, Inc. Stockholders of the Investigation into Lamb Weston and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Lamb Weston (LW) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 16, 2025
AMYLYX INVESTIGATION: Bragar Eagel & Squire, P.C. Urges Amylyx Investors to Contact the Firm Regarding Ongoing Investigation into Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Amylyx (AMLX) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 16, 2025
SKYWORKS REMINDER: Bragar Eagel & Squire, P.C. is Reminds Long-Term Skyworks Solutions, Inc. Stockholders and to Contact the Firm Regarding Ongoing Investigation
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Skyworks (SWKS) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 16, 2025
APPLOVIN REMINDER: Bragar Eagel & Squire, P.C. Reminds AppLovin Long-Term Stockholders to Contact the Firm Regarding Ongoing Investigation
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In AppLovin (APP) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 16, 2025
Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details
WAYNE, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, November 6, 2025.
By Teleflex Incorporated · Via GlobeNewswire · October 16, 2025
iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025
SAN FRANCISCO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third quarter 2025 after the close of trading on Thursday, October 30, 2025. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
By iRhythm · Via GlobeNewswire · October 16, 2025
Beyond Meat Announces Release at 5:00 p.m., New York City time, of Lock-up Restrictions on Shares that were Exchanged for Existing Convertible Notes in its Exchange Offer
EL SEGUNDO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND) (the “Company” or “Beyond Meat”), a leader in plant-based meat, today announced that the lock-up restrictions that applied to certain of the 316,150,176 shares of its common stock (the “New Shares”) that were issued on October 15, 2025, in connection with the Company’s exchange offer (the “Exchange Offer”) for its 0% Convertible Senior Notes due 2027 (the “Existing Convertible Notes”) will expire as of 5:00 p.m., New York City time, on the date hereof.
By Beyond Meat, Inc. · Via GlobeNewswire · October 16, 2025
NETCLASS TECHNOLOGY INC Announces Updated Earnings Results for the First Half of Fiscal Year 2025
SINGAPORE and HONG KONG, Oct. 16, 2025 (GLOBE NEWSWIRE) -- NETCLASS TECHNOLOGY INC (Nasdaq: NTCL; the “Company” or “NetClass”), a leading B2B smart education IT solutions provider with offices in Shanghai, Hong Kong, Singapore and Tokyo, today corrected its unaudited condensed consolidated financial results previously announced on September 30, 2025. The financial results have not been reviewed by an independent certified public accountant for the six months ended March 31, 2025.
By NETCLASS TECHNOLOGY INC. · Via GlobeNewswire · October 16, 2025
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
AUDUBON, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended September 30, 2025 after the market close on Thursday, November 6, 2025. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
By Globus Medical · Via GlobeNewswire · October 16, 2025
Standard Lithium Announces Proposed Public Offering of Common Shares
VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI), a leading near-commercial lithium company, announced that it intends to offer and sell common shares (the “Common Shares”) in an underwritten public offering of $120,000,000 (the “Offering”). The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering. Standard Lithium also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the Common Shares sold under the Offering at the public offering price.
By Standard Lithium · Via GlobeNewswire · October 16, 2025
SiriusPoint Announces Date for Third Quarter 2025 Earnings Release
HAMILTON, Bermuda, Oct. 16, 2025 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (NYSE: SPNT) (“SiriusPoint” or the “Company”) today announced that it is planning to release its third quarter 2025 financial results after the market close on Thursday, October 30, 2025. The Company will also hold a conference call, including a question-and-answer session, to discuss its financial results at 8:30 am (Eastern Time) on Friday, October 31, 2025.
By SiriusPoint Ltd. · Via GlobeNewswire · October 16, 2025
Gemini to Announce Third Quarter 2025 Results on November 10, 2025
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Gemini Space Station, Inc. (Gemini) (NASDAQ: GEMI), a global crypto platform, today announced it will release its third quarter 2025 financial results at approximately 4:05 pm ET on Monday, November 10, 2025. Management will host a conference call on the same day (November 10, 2025) at 5:00 pm ET to discuss the results.
By Gemini Space Station, Inc. · Via GlobeNewswire · October 16, 2025
WillScot to Announce Third Quarter 2025 Results on November 6, 2025 and to Present at an Upcoming Investor Conference in November
PHOENIX, Oct. 16, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced that it will release its third quarter 2025 financial results on November 6, 2025, after market close.
By WillScot · Via GlobeNewswire · October 16, 2025
Slide to Report Third Quarter 2025 Results on Wednesday, November 5, 2025
TAMPA, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Slide Insurance Holdings, Inc. (“Slide”) (Nasdaq: SLDE) today announced it will release its third quarter 2025 financial results after the stock market closes on Wednesday, November 5, 2025.
By Slide Insurance Holdings, Inc. · Via GlobeNewswire · October 16, 2025
Macerich Schedules Third Quarter 2025 Earnings Release and Conference Call
SANTA MONICA, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) --
By Macerich Company · Via GlobeNewswire · October 16, 2025
atai Life Sciences Announces Proposed Public Offering of Common Shares
NEW YORK and AMSTERDAM, Oct. 16, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company focused on transforming the treatment of mental health disorders, today announced the commencement of a proposed registered underwritten offering of its common shares. atai expects to grant the underwriters a 30-day option to purchase additional common shares at the public offering price, less the underwriting discount. All common shares to be sold in the offering will be sold by atai. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
By atai Life Sciences · Via GlobeNewswire · October 16, 2025
New Marine Team Leading Scoular’s Fishmeal and Fish Oil Business
Omaha, Nebraska, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Scoular, which operates one of the largest and most diverse fishmeal and fish oil businesses globally, today announced new leadership. 
By Scoular · Via GlobeNewswire · October 16, 2025
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
NEW YORK and AMSTERDAM, Oct. 16, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), and Beckley Psytech Limited (“Beckley Psytech”), who previously announced a planned strategic combination to create a global leader in transformative mental health therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) to BPL-003 (mebufotenin benzoate) nasal spray for adult patients with treatment-resistant depression (TRD).
By atai Life Sciences · Via GlobeNewswire · October 16, 2025
LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025
SCOTTSDALE, Ariz., Oct. 16, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its third quarter 2025 earnings release before the market opens on Thursday, November 6, 2025.
By LifeStance Health, Inc. · Via GlobeNewswire · October 16, 2025
Lite Strategy Celebrates 14th Anniversary of Litecoin, Taps Institutional Signals Ahead of 2026
Marking 14 years of continuous operation, millions of transactions, and demonstrated reliability across the global blockchain ecosystem, Litecoin sets the benchmark for longevity and performance as digital assets evolve into institutional-grade hard money.
By Lite Strategy, Inc. · Via GlobeNewswire · October 16, 2025
Bank OZK Announces Record Third Quarter 2025 Earnings
LITTLE ROCK, Ark., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Bank OZK (the “Bank”) (Nasdaq: OZK) today announced that net income available to common stockholders for the third quarter of 2025 was a record $180.5 million, a 1.9% increase from $177.1 million for the third quarter of 2024. For the first nine months of 2025, net income available to common stockholders was $527.4 million, a 1.0% increase from $522.1 million for the first nine months of 2024. Diluted earnings per common share ("EPS") for the third quarter of 2025 were a record $1.59, a 2.6% increase from $1.55 for the third quarter of 2024. EPS for the first nine months of 2025 were $4.64, a 1.3% increase from $4.58 for the first nine months of 2024.
By Bank OZK · Via GlobeNewswire · October 16, 2025
ARRAY Technologies, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call
ALBUQUERQUE, N.M., Oct. 16, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies, Inc. (the “Company” or “ARRAY”) (NASDAQ: ARRY), a leading global provider of solar tracking technology and fixed-tilt system products, software, services and foundation solutions, today announced that the Company will release its third quarter 2025 results after the market closes on Wednesday, November 5, 2025, to be followed by a conference call at 5:00 p.m. (Eastern Time) that same day.
By Array Technologies, Inc. · Via GlobeNewswire · October 16, 2025
Seer to Report Third Quarter 2025 Financial Results on November 6, 2025
REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the third quarter 2025 on Thursday, November 6, 2025. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
By Seer, Inc. · Via GlobeNewswire · October 16, 2025
Allbirds Announces Third Quarter 2025 Earnings Conference Call
SAN FRANCISCO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that innovates with sustainable materials to make better products in a better way, today announced that its third quarter 2025 financial results will be released after market close on Thursday, November 6, 2025. The company will host a conference call to discuss the results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day.
By Allbirds, Inc. · Via GlobeNewswire · October 16, 2025
onsemi to Announce Third Quarter Financial Results
SCOTTSDALE, Ariz., Oct. 16, 2025 (GLOBE NEWSWIRE) -- onsemi (Nasdaq: ON) plans to announce its financial results for the third quarter, which ended October 3, 2025, before the market opens on Monday, November 3, 2025.
By onsemi · Via GlobeNewswire · October 16, 2025
TeraWulf Inc. Announces Pricing of $3.2 Billion of Senior Secured Notes
EASTON, Md., Oct. 16, 2025 (GLOBE NEWSWIRE) -- TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf”), a leading owner and operator of vertically integrated, sustainable digital infrastructure, today announced that its wholly-owned subsidiary, WULF Compute LLC (“WULF Compute”), has priced a $3.2 billion offering (the “Offering”) of 7.750% senior secured notes due 2030 (the “Notes”) at par. The Notes will be sold in a private offering to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).The Offering is expected to close on October 23, 2025, subject to market and other conditions.
By TeraWulf Inc. · Via GlobeNewswire · October 16, 2025
AppFolio, Inc. Announces Date of Third Quarter 2025 Financial Results Conference Call
SANTA BARBARA, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- AppFolio, Inc. (NASDAQ: APPF) today announced that it will report its third quarter 2025 financial results after the close of the U.S. financial markets on Thursday, October 30, 2025.
By AppFolio, Inc. · Via GlobeNewswire · October 16, 2025
Brilliant Earth to Report Third Quarter 2025 Financial Results on November 5th
SAN FRANCISCO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that it will report third quarter 2025 earnings results before the market opens on Wednesday, November 5, 2025.
By Brilliant Earth, LLC · Via GlobeNewswire · October 16, 2025
Middlesex Water Company to Report Third Quarter 2025 Earnings on October 31
ISELIN, N.J., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Middlesex Water Company (NASDAQ: MSEX) plans to report financial results for the third quarter ended September 30, 2025, after the market close on October 31, 2025. The press release and the company’s third quarter 2025 Form 10-Q will be available in the Investors section of the company’s website.
By Middlesex Water Company · Via GlobeNewswire · October 16, 2025
Orion Group Holdings to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025
Conference Call to be held Wednesday, October 29, 2025, at 8:00 a.m. Central Time
By Orion Group Holdings, Inc. · Via GlobeNewswire · October 16, 2025
Fossil Group Announces Notice of Plan Meeting
IN THE MATTER OF FOSSIL (UK) GLOBAL SERVICES LTD
By Fossil Group, Inc. · Via GlobeNewswire · October 16, 2025
DBM Global to Pay Cash Dividend
PHOENIX, Oct. 16, 2025 (GLOBE NEWSWIRE) -- DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE Corp. (NYSE: VATE), announced today that it will pay a cash dividend of approximately $8.8 million, or $2.28 per share, on November 10, 2025 to DBMG’s stockholders of record at the close of business on October 27, 2025.
By DBM Global Inc. · Via GlobeNewswire · October 16, 2025
SPS Commerce Announces Date of Third Quarter 2025 Financial Results
MINNEAPOLIS, Oct. 16, 2025 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced that it will issue its financial results for the third quarter ended September 30, 2025, after the market close on Thursday, October 30, 2025. SPS Commerce will host a call to discuss the results at 3:30 p.m. Central Time (4:30 p.m. Eastern Time) on the same day.
By SPS Commerce, Inc. · Via GlobeNewswire · October 16, 2025
ACM Research to Release Third Quarter 2025 Financial Results on November 5, 2025
FREMONT, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM”) (NASDAQ: ACMR) announced today that it will release its financial results for the third quarter of 2025 before the U.S. market open on Wednesday, November 5, 2025. ACM will conduct a corresponding conference call at 8:00 a.m. U.S. Eastern Time (9:00 p.m. China Time) to discuss the results.
By ACM Research, Inc. · Via GlobeNewswire · October 16, 2025
Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update
Prioritization of refractory rheumatoid arthritis (RA) as lead indication for AlloNK® development 
By Artiva Biotherapeutics, Inc. · Via GlobeNewswire · October 16, 2025
Dayforce to Announce Third Quarter 2025 Financial Results on October 29th
MINNEAPOLIS and TORONTO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE:DAY) (TSX:DAY), a global human capital management (HCM) leader that makes work life better, today announced that it will release third quarter 2025 financial results after the close of regular market trading on Wednesday, October 29, 2025.
By Dayforce, Inc. · Via GlobeNewswire · October 16, 2025
RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting
ALISO VIEJO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced it will be featured in multiple Live Learning Sessions at Booth #2931 during the American Academy of Ophthalmology Annual Meeting (AAO 2025), taking place October 18–20 at the Orange County Convention Center in Orlando, Fla.
By RxSight, Inc. · Via GlobeNewswire · October 16, 2025
MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) INVESTOR ALERT Investors With Large Losses in MoonLake Immunotherapeutics Should Contact Bernstein Liebhard LLP To Discuss Their Rights
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, inclusive.
By Bernstein Liebhard LLP · Via GlobeNewswire · October 16, 2025
CSX Corp. Announces Third Quarter 2025 Results
JACKSONVILLE, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) today announced third quarter operating income of $1.09 billion and net earnings of $694 million, or $0.37 per share. Excluding a non-cash goodwill impairment of $164 million in this year’s third quarter results, adjusted operating income was $1.25 billion and adjusted net earnings were $818 million, or $0.44 per share. In the third quarter of 2024, the company reported operating income of $1.35 billion and net earnings of $894 million, or $0.46 per share.
By CSX Corporation · Via GlobeNewswire · October 16, 2025
Galapagos Announces Appointment of Fred Blakeslee as General Counsel
Mechelen, Belgium; October 16, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced the appointment of Mr. Fred Blakeslee as Executive Vice President and General Counsel effective October 16, 2025. Blakeslee is succeeding Ms. Valeria Cnossen, who will leave the Company after a short transition period.
By Galapagos NV · Via GlobeNewswire · October 16, 2025
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced a proposed public offering of its common stock and, in lieu of common stock to certain investors, prefunded warrants to purchase shares of common stock. All securities in the offering will be offered by Praxis. In addition, Praxis intends to grant the underwriters a 30-day option to purchase additional shares of common stock in an amount up to 15% of the shares of common stock (or prefunded warrants in lieu thereof) sold in the offering at the public offering price, less the underwriting discount and commission.
By Praxis Precision Medicines, Inc. · Via GlobeNewswire · October 16, 2025
Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL
 ○ Efficacy: ORR of 68% with lasme-cel Process 2 (n=22), 83% at RP2D (n=12) and 100% in the target Phase 2 population (n=9)
By Cellectis Inc. · Via GlobeNewswire · October 16, 2025
Donegal Group Inc. Announces Quarterly Dividend
MARIETTA, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) reported today that its board of directors declared a regular quarterly cash dividend of $0.1825 per share of the Company’s Class A common stock and $0.165 per share of the Company’s Class B common stock. The dividends are payable on November 17, 2025 to stockholders of record as of the close of business on November 3, 2025.
By Donegal Group, Inc. · Via GlobeNewswire · October 16, 2025
In Newly Released Fantasy Fiction, Heroes Unite to Avenge Fallen Loved Ones and Defeat Demonic Evil
A band of heroes unites to confront a demon-spawned evil, as Palmetto Publishing presents a tale of vengeance, magic, and destiny.
By Palmetto Publishing · Via GlobeNewswire · October 16, 2025
MICHELIN ANNOUNCES FULL ROLLOUT OF TREADEYE TECHNOLOGY ACROSS U.S. RETREAD NETWORK
Michelin, a global leader in tire innovation, is proud to announce the full deployment of TreadEye, a proprietary technology developed to enhance the retread process and deliver measurable value to fleets. After a period of phased implementation, TreadEye is now available across the Michelin Retread Technologies franchise network in the United States.
By MICHELIN · Via GlobeNewswire · October 16, 2025
AB Science provides intitial Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
PRESS RELEASE
By AB Science · Via GlobeNewswire · October 16, 2025
New Report Exposes How U.S. Subsidizes Massive Food Waste Through Farm Feed
On World Food Day, new report reveals taxpayers fund system that wastes 160 million tons of food annually—enough to feed 287.8 million people—while 47 million Americans face food insecurity
By Compassion in World Farming · Via GlobeNewswire · October 16, 2025
Girlstart Wins Inaugural US F1® Allwyn Global Community Award
AUSTIN, Texas, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Allwyn, the multi-national lottery-led entertainment company, and Formula 1 have announced Girlstart as the first US winner of the F1® Allwyn Global Community Award and recipient of a €100,000 donation (equivalent to over $117,000). The donation, courtesy of Allwyn, will be used to further Girlstart’s positive work in the local community by introducing STEM careers to girls who have been historically marginalised.
By Allwyn · Via GlobeNewswire · October 16, 2025